Document Detail


Development, use and evaluation of drugs: the dominating technology in the health care system.
MedLine Citation:
PMID:  3303354     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The article presents various perspectives of drug technology and health care policy in Denmark. Drugs dominate as the most widely used treatment technology in the health care system and the use of drugs is steadily increasing. The pharmaceutical industry's development of drugs is based on an economic estimate of developments, expenditures, marketing costs and the anticipated share of the market. Controlled clinical trials have become the main form of documentation required by the health authorities. This method is insufficient to evaluate the (side) effects of the drugs when in actual use. Drugs fit perfectly the technical perception of disease, a perception which prevails in the pharmaceutical industry, medical science and in the treatment of disease. This perception believes that a disease is due to an attack or dysfunction in the biological-mechanical conditions of the individual. Drugs offer a standard solution to health problems independent of the individuals' social life. Thus drugs become a tool which function in agreement with the disintegrated and achievement-orientated approach to disease as it is organized today. In general the statements in this article are not limited to special Danish circumstances but are valid for other countries as well [1, 2]. (Norris R. Pills, Pesticides & Profits. North River Press, 1982; Braithwaite J. Corporate Crime in the Pharmaceutical Industry. Routledge & Kegan Paul, London, 1984) The empirical data in this article derive from Denmark, however.
Authors:
E H Hansen; L Launsø
Related Documents :
20054854 - Postmarketing in vitro/in vivo assessment of fixed dose combination products of first l...
17094144 - Conference report: bio-international 2005.
3443044 - Drugs and the relationships between university, industry and legislation.
16471424 - Strategy for assessing the leachables impact of a material change made in a container/c...
7237434 - Differential enhancement of antitumor effectiveness by phospholipid vesicles (liposomes).
23684914 - Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Social science & medicine (1982)     Volume:  25     ISSN:  0277-9536     ISO Abbreviation:  Soc Sci Med     Publication Date:  1987  
Date Detail:
Created Date:  1987-09-23     Completed Date:  1987-09-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8303205     Medline TA:  Soc Sci Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  65-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Delivery of Health Care*
Denmark
Drug Industry*
Drug Utilization
Health Policy
Humans
Physicians, Family
Placebos
Safety
Technology, Pharmaceutical
Therapeutics
Chemical
Reg. No./Substance:
0/Placebos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The demand for health inputs and their impact on the black neonatal mortality rate in the U.S.
Next Document:  Evaluation of fever in infants less than 8 weeks old.